Re: Fwd: FDA MedWatch: Public Health Advisory: FDA Recommendations Concern ing the Use of NSAIDs

[Guest guest]

ly, we're also talking about ibuprophen here, which, when having pain of fever or swelling, I prefer, but it IS included with this. But why they are not mentioning it, I just don't understand. It is a 2 inhibitor, in fact, much more so than Vioxx or the others. As a matter of fact, it inhibits BOTH 1 and 2!! I was trying to post something on this several wks ago, but my computer froze up (which is happening more often lately; frustrating!), and I never went back looking for the article again.

FDA MedWatch: Public Health Advisory: FDA Recommendations Concern ing the Use of NSAIDsTo: MEDWATCH@...MedWatch - The FDA Safety Information and Adverse Event Reporting ProgramThe FDA issued a Public Health Advisory summarizing the agency's recentrecommendations concerning the use of non-steroidal anti-inflammatory drugproducts (NSAIDs), including those known as COX-2 selective agents. Thisadvisory was issued because of recently released data from controlledclinical trials showing that the COX-2 selective agents (Vioxx, Celebrex,and Bextra) may be associated with an increased risk of seriouscardiovascular events (heart attack and stroke) and after release ofpreliminary results from a long-term clinical trial whi! ch suggested thatlong-term use of a non-selective NSAID, naproxen (sold as Aleve, Naprosynand other trade name and generic products), may be associated with anincreased cardiovascular risk compared to placebo. The public healthadvisory is an interim measure, pending further review by FDA of data thatcontinue to be collected.